TABLE 3.

Key quality metrics that can guide quality‐improvement efforts.

Proposed quality metric	90% compliance goal
Pathology diagnostic turnaround time (i.e., time from specimen received in pathology to final pathologic diagnosis)	≤3 working days
Biomarker test order turnaround time (i.e., time from final pathologic diagnosis to biomarker test ordered)	≤2 working days
Pathology biomarker turnaround time (i.e., time from final pathologic diagnosis and/or biomarker test ordered to specimen sent to molecular laboratory) for eligible patients with NSCLC	≤3 working days (Lindeman 2013 29 )
Molecular biomarker turnaround time (i.e., time from specimen received in molecular testing laboratory to reporting of all biomarker results) for eligible patients with NSCLC	≤10 working days (Lindeman 2013 29 )
Overall biomarker turnaround time (i.e., time from final pathologic diagnosis rendered to reporting of all biomarker results) for eligible patients with NSCLC	≤14 working days

Abbreviation: NSCLC, non–small cell lung cancer.